1. Home
  2. ICU vs APM Comparison

ICU vs APM Comparison

Compare ICU & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICU
  • APM
  • Stock Information
  • Founded
  • ICU 2018
  • APM 2010
  • Country
  • ICU United States
  • APM United Kingdom
  • Employees
  • ICU N/A
  • APM N/A
  • Industry
  • ICU Biotechnology: Pharmaceutical Preparations
  • APM Biotechnology: Pharmaceutical Preparations
  • Sector
  • ICU Health Care
  • APM Health Care
  • Exchange
  • ICU Nasdaq
  • APM Nasdaq
  • Market Cap
  • ICU 10.4M
  • APM 6.7M
  • IPO Year
  • ICU N/A
  • APM 2018
  • Fundamental
  • Price
  • ICU $0.57
  • APM $0.95
  • Analyst Decision
  • ICU
  • APM
  • Analyst Count
  • ICU 0
  • APM 0
  • Target Price
  • ICU N/A
  • APM N/A
  • AVG Volume (30 Days)
  • ICU 19.3M
  • APM 26.3K
  • Earning Date
  • ICU 08-12-2025
  • APM 07-22-2025
  • Dividend Yield
  • ICU N/A
  • APM N/A
  • EPS Growth
  • ICU N/A
  • APM N/A
  • EPS
  • ICU N/A
  • APM N/A
  • Revenue
  • ICU $428,000.00
  • APM N/A
  • Revenue This Year
  • ICU $754.07
  • APM N/A
  • Revenue Next Year
  • ICU $100.09
  • APM N/A
  • P/E Ratio
  • ICU N/A
  • APM N/A
  • Revenue Growth
  • ICU N/A
  • APM N/A
  • 52 Week Low
  • ICU $0.31
  • APM $0.46
  • 52 Week High
  • ICU $9.56
  • APM $7.49
  • Technical
  • Relative Strength Index (RSI)
  • ICU 38.28
  • APM 46.52
  • Support Level
  • ICU $0.51
  • APM $0.86
  • Resistance Level
  • ICU $0.91
  • APM $1.00
  • Average True Range (ATR)
  • ICU 0.13
  • APM 0.06
  • MACD
  • ICU 0.03
  • APM -0.00
  • Stochastic Oscillator
  • ICU 32.90
  • APM 37.69

About ICU SeaStar Medical Holding Corporation

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.

About APM Aptorum Group Limited

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

Share on Social Networks: